Lori M. Dulabon

1.5k citations
18 papers · 972 indexed · h-index 9
Topics
Renal cell carcinoma treatment (9 papers)Renal and related cancers (5 papers)Renal and Vascular Pathologies (5 papers)

In The Last Decade

Lori M. Dulabon

17 papers receiving 951 citations

Peers

Lori M. Dulabon
Comparison fields: 5 of 59
  • Pulmonary and Respiratory Medicine 760
  • Molecular Biology 429
  • Surgery 364
  • Pediatrics, Perinatology and Child Health 153
  • Urology 141
Replace Firas G. Petros with:
Firas G. Petros United States
Rebecca A. Campbell United States
Osamu Matsuura Japan
Ari Adamy United States
Richard Gastón France
Carlo Introini Italy
Turgut Alkıbay Türkiye
Ashraf Mosharafa Egypt
Adel Nabeeh Egypt
Khaled Hafez United States
Lori M. Dulabon relative to Firas G. Petros United States Firas G. Petros's profile →
Citations per field
00.5×1.5×2.2×
Firas G. Petros · 1×
Citations per year

Countries citing papers authored by Lori M. Dulabon

Since Specialization
Citations

This map shows the geographic impact of Lori M. Dulabon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori M. Dulabon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori M. Dulabon more than expected).

Fields of papers citing papers by Lori M. Dulabon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori M. Dulabon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori M. Dulabon. The network helps show where Lori M. Dulabon may publish in the future.

Co-authorship network of co-authors of Lori M. Dulabon

This figure shows the co-authorship network connecting the top 25 collaborators of Lori M. Dulabon. A scholar is included among the top collaborators of Lori M. Dulabon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori M. Dulabon. Lori M. Dulabon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 8
2 57
3 4
4 93
5 144
6 113
7 12
8
Metastatic esophageal adenocarcinoma to the prostate presenting with bilateral ureteral obstruction.
3
9 0
10 3
11 1
12 1
13 55
14 373
15 7
16
Intrarenal pseudoaneurysm presenting with microscopic hematuria and right flank pain.
8
17 38
18 52

About Lori M. Dulabon

Lori M. Dulabon is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 18 papers that have together received 972 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Renal and related cancers (5 papers) and Renal and Vascular Pathologies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (760 citations), Urology (141 citations) and Surgery (364 citations). Lori M. Dulabon has collaborated with scholars based in United States, Austria and Spain. Frequent co-authors include Michael Stifelman, Craig Rogers, Sam B. Bhayani, Agnes J. Wang, Michael E. Lipkin, Brian M. Benway, Manish Patel, Justine Schober, William C. Huang and William T. Lowrance. Their work appears in journals such as Cancer, Journal of Clinical Microbiology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026